EpiCypher, Inc.的封面图片
EpiCypher, Inc.

EpiCypher, Inc.

生物技术研究

Durham,North Carolina 3,144 位关注者

Accelerating technology development to improve human health

关于我们

A pioneer in the field of epigenetics and chromatin biology, EpiCypher is a bioscience company developing transformative technologies and delivering superior products to researchers world-wide. Our technologies and products are making studies possible that were not imaginable just a few years ago. Our renowned chromatin researchers possess expertise and unique insight into chromatin biology and drug discovery that benefit our customers in ways other companies cannot. Epigenetics, the study of changes in heritable traits that occur independent of alterations in changes in the underlying DNA sequence, is an emerging and important area of biomedical research with broad impact on human health and disease.

网站
https://www.epicypher.com
所属行业
生物技术研究
规模
11-50 人
总部
Durham,North Carolina
类型
私人持股
创立
2012
领域
epigenetics、chromatin、histone、nucleosome、histone modification、histone methylation、histone acetylation、histone binding proteins、epigenomics、recombinant nucleosome、designer nucleosome、drug discovery、SPIKE-IN 、ChIP、Chromatin Immunoprecipitation和High Throughput Assay Development

地点

  • 主要

    801 Capitola Drive

    Suite #9

    US,North Carolina,Durham,27713

    获取路线

EpiCypher, Inc.员工

动态

相似主页

查看职位

融资

EpiCypher, Inc. 共 4 轮

上一轮

未知

US$3,300,000.00

Crunchbase 上查看更多信息